Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00347373 · ClinicalTrials.gov registry record · NA

Effect of Conjugated Linoleic Acid Supplement on Body Composition

A NA study of Obesity, sponsored by University of North Carolina.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT00347373 is a NA study of Obesity that has completed, run by University of North Carolina. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00347373, a NA study of Obesity, has completed, sponsored by University of North Carolina.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.

Conditions Studied

Interventions

  • DRUG Tonalin Conjugated linoleic acid (dietary supplement)

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2004-08
Est. Completion 2005-09
Phase NA

Sponsor

University of North Carolina

14 total trials

What the Registry Record Tells You About NCT00347373

The ClinicalTrials.gov registry entry for NCT00347373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is University of North Carolina, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Tonalin Conjugated linoleic acid (dietary supplement) is the first listed.

NCT00347373 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00347373 about?

NCT00347373 is a clinical study titled "Effect of Conjugated Linoleic Acid Supplement on Body Composition". The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve we...

What is the current status of trial NCT00347373?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2004-08. Estimated completion is 2005-09.

What conditions does trial NCT00347373 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00347373?

The interventions under investigation include: Tonalin Conjugated linoleic acid (dietary supplement) (DRUG).

Who is sponsoring clinical trial NCT00347373?

This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00347373 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.